ArticleThe New England journal of medicine2026
Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer.
Sibylle Loibl et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
37 papers cite it
this papercites it
ArticleThe New England journal of medicine2026
Sibylle Loibl et al.PubMed ↗Publisher ↗
No numbers read from the abstract.